Indole-Based Tubulin Inhibitors: Binding Modes and SARs Investigations

被引:20
作者
Tang, Sheng [1 ]
Zhou, Zhihui [1 ]
Jiang, Zhiyan [1 ]
Zhu, Wufu [1 ]
Qiao, Dan [1 ]
机构
[1] Jiangxi Sci & Technol Normal Univ, Sch Pharm, Nanchang 330013, Peoples R China
来源
MOLECULES | 2022年 / 27卷 / 05期
关键词
tubulin inhibitors; indole; cancer; binding modes; SARs investigations; COMBRETASTATIN A-4 ANALOGS; BIOLOGICAL EVALUATION; MOLECULAR DOCKING; POLYMERIZATION INHIBITORS; CONCISE SYNTHESIS; ANTITUMOR AGENTS; CELL-GROWTH; DERIVATIVES; POTENT; ANTITUBULIN;
D O I
10.3390/molecules27051587
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tubulin inhibitors can interfere with normal cell mitosis and inhibit cell proliferation through interfering with the normal structure and function of microtubules, forming spindle filaments. Indole, as a privileged pharmacological skeleton, has been widely used in anti-cancer inhibitors. A variety of alkaloids containing an indole core obtained from natural sources have been proven to inhibit tubulin polymerization, and an ever-increasing number of synthetic indole-based tubulin inhibitors have been reported. Among these, several kinds of indole-based derivatives, such as TMP analogues, aroylindoles, arylthioindoles, fused indole, carbazoles, azacarbolines, alkaloid nortopsentin analogues and bis-indole derivatives, have shown good inhibition activities towards tubulin polymerization. The binding modes and SARs investigations of synthetic indole derivatives, along with a brief mechanism on their anti-tubulin activity, are presented in this review.
引用
收藏
页数:23
相关论文
共 88 条
[1]   N-(2-methyl-indol-1H-5-yl)-1-naphthalenesulfonamide: A novel reversible antimitotic agent inhibiting cancer cell motility [J].
Aceves-Luquero, Clara ;
Galiana-Rosello, Cristina ;
Ramis, Guillem ;
Villalonga-Planells, Ruth ;
Garcia-Espana, Enrique ;
Fernandez de Mattos, Silvia ;
Pelaez, Rafael ;
Llinares, Jose M. ;
Eugenia Gonzalez-Rosende, M. ;
Villalonga, Priam .
BIOCHEMICAL PHARMACOLOGY, 2016, 115 :28-42
[2]  
Alvarez M., 1991, CHEMINFORM, V22, P759, DOI [10.1002/chin.199151364, DOI 10.1002/CHIN.199151364]
[3]   Mapping the binding site of colchicinoids on β-tubulin -: 2-chloroacetyl-2-demethylthiocolchicine covalently reacts predominantly with cysteine 239 and secondarily with cysteine 354 [J].
Bai, RL ;
Covell, DG ;
Pei, XF ;
Ewell, JB ;
Nguyen, NY ;
Brossi, A ;
Hamel, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) :40443-40452
[4]   Non-Operative Management of Appendicitis: Evolution, not Revolution [J].
Barie, Philip S. .
SURGICAL INFECTIONS, 2021, 22 (10) :991-1003
[5]   A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivo glioblastoma models [J].
Boumendjel, Ahcene ;
McLeer-Florin, Anne ;
Champelovier, Pierre ;
Allegro, Diane ;
Muhammad, Dima ;
Souard, Florence ;
Derouazi, Madiha ;
Peyrot, Vincent ;
Toussaint, Bertrand ;
Boutonnat, Jean .
BMC CANCER, 2009, 9
[6]   Small molecule vascular disrupting agents: Potential new drugs for cancer treatment [J].
Cai, Sui X. .
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2007, 2 (01) :79-101
[7]   Efficient and simple synthesis of 6-Aryl-1,4-dimethyl-9H-carbazoles [J].
Caruso, Anna ;
Voisin-Chiret, Anne Sophie ;
Lancelot, Jean-Charles ;
Sinicropi, Maria Stefania ;
Garofalo, Antonio ;
Rault, Sylvain .
MOLECULES, 2008, 13 (06) :1312-1320
[8]   Novel nicotinoyl pyrazoline derivates bearing N-methyl indole moiety as antitumor agents: Design, synthesis and evaluation [J].
Chen, Kun ;
Zhang, Ya-Liang ;
Fan, Jing ;
Ma, Xiang ;
Qin, Ya-Juan ;
Zhu, Hai-Liang .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 156 :722-737
[9]   Synthesis, biological evaluation, and molecular docking investigation of 3-amidoindoles as potent tubulin polymerization inhibitors [J].
Chen, Peng ;
Zhuang, Yu-Xin ;
Diao, Peng-Cheng ;
Yang, Fang ;
Wu, Shao-Yu ;
Lv, Lin ;
You, Wen-Wei ;
Zhao, Pei-Liang .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 162 :525-533
[10]   Discovery of a Novel Series of Imidazo[1,2-a]pyrimidine Derivatives as Potent and Orally Bioavailable Lipoprotein-Associated Phospholipase A2 Inhibitors [J].
Chen, Xinde ;
Xu, Wenwei ;
Wang, Kai ;
Mo, Mingguang ;
Zhang, Wei ;
Du, Lili ;
Yuan, Xiaojing ;
Xu, Yechun ;
Wang, Yiping ;
Shen, Jianhua .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (21) :8529-8541